Opto Circuits Group Company, Cardiac Science Corporation, Wins Nearly $23 Million Against Zoll in Case Over Wearable Defibrillator Technology

BENGALURU, June 8, 2015 /PRNewswire/ --

Cardiac Science Corporation, a group company of Opto Circuits (India) Ltd. (Bloomberg: OPTCIN; Reuters: OPTO.NS; NSE: OPTOCIRCUI; BSE: 532391) and a global leader in automated external defibrillators (AEDs), is celebrating a victory in a long-standing dispute over the company's wearable defibrillator technology. On May 22, a 12-person jury in Los Angeles Superior Court unanimously decided in favor of the company's breach of contract claims against Zoll Medical Corporation, and Zoll LifeCor Corporation, awarding Cardiac Science $22,991,985 in lost royalties. Cardiac Science was represented by Patterson Thuente IP in the dispute.

Vinod Ramnani, Chairman and Managing Director, Opto Circuits (India) Ltd. stated, "This unanimous jury verdict represents a significant victory for Cardiac Science and the extensive damages validate the significant value of Cardiac Science's wearable defibrillator technology and other technologies in AED space. We will continue our commitment to protect our intellectual property and innovation."

The dispute relates to the company's patented wearable defibrillator technology. In 2002, LifeCor began marketing its LifeVest® product, which infringed a number of Cardiac Science's patents. To avoid infringement claims, LifeCor entered into a cross-license agreement with Cardiac Science and was able to continue selling its device. However, once Zoll Medical acquired Lifecor in 2006, they stopped paying royalties associated with the cross-license agreement. Cardiac Science sued Zoll Medical and Zoll Lifecor, for breach of contract in 2011.

About Cardiac Science  

Cardiac Science, a group company of Opto Circuits (India) Ltd., develops, manufactures, and markets automated external defibrillators (AED). The company also provides a portfolio of training, maintenance, and support services for AEDs. Cardiac Science is headquartered in Waukesha, Wisconsin. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 1.800.426.0337 or visit www.cardiacscience.com

About Opto Circuits (India) Limited  

Opto Circuits (India) Ltd. (OCI) is a vertically integrated multinational medical technology group that specializes in primary, acute and critical care products for the global markets. Group companies such as Cardiac Science, Criticare, Eurocor, Mediaid, AMDL and Unetixs Vascular are leaders in cardiac and vital signs monitors, emergency cardiac care equipment, vascular treatments and sensing technologies. Our USFDA listed and CE marked products are marketed in more than 150 countries and sold through direct and indirect sales channels across many emerging and developing economies. We've been ranked in Forbes' Asia's 200 Best under a Billion lists in 2008, 2009 and 2011.

For more information, please visit www.optoindia.com

Media Contact:
Shahab Shaikh
[email protected]
+91-9320897525
Concept Public Relations India Limited